VEGFA and hypertensive disorder: Overexpression of soluble VEGFR-1/sFlt-1 in the placenta in preeclampsia contributes to the major pathological symptoms of this condition in affected patients, including hypertension and renal dysfunction, most likely by blocking VEGF-A [23–25], so resulting in endothelial dysfunction and organ injury [25].